CHA Comments on Stimulant Medication Shortages

Children’s health groups are asking HHS and the DEA to convene stakeholders to identify actionable solutions about ongoing stimulant medication shortages.
Download

Children's Hospital Association and other children’s health groups submitted joint comments to the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) requesting the convening of stakeholders to identify actionable solutions about ongoing stimulant medication shortages.

Our comments highlight the long-term negative impacts that children and their families may experience due to untreated attention deficit hyperactivity disorder and that these shortages exacerbate existing health disparities among families enrolled in Medicaid and CHIP.

Related Content

Why 340B Is Essential for Children's Health

The program makes life-saving drugs more affordable for hospitals that care for our nation’s children.

Oct. 07, 2025

CHA Applauds HHS’ Funding Boost for Childhood Cancer Research, Urges Further Action

Children's Hospital Association encourages policymakers and leaders to keep investing in better research, innovation, and patient care for children and adolescents with cancer.

Oct. 02, 2025

Why Life-Saving Pediatric Treatments Need NIH Funding

National Institutes of Health research funding is responsible for many curative and life-enhancing medical advancements for children.

Sep. 30, 2025